EirGen Pharma: IMP Licence

EirGen Pharma are pleased to announce the successful completion of a Facilities and Quality Systems Inspection by the Irish Medicines Board which will result in the granting of a Manufacturing Authorisation for the supply of Investigational New Products based on EU Directive 2001/20/EC.